Article
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapies
2025-07-04
Abstract excerpt
<title>Abstract</title> <p>Patients with lymphoma are at increased risk of severe infections, including SARS-CoV-2, due to immune suppression. Using multidimensional spectral flow cytometry and serology, we characterized in-depth immune responses in 50 SARS-CoV-2 vaccinated lymphoma patients across12 lymphoma subtypes, treated with anti-CD20 antibody (aCD20) ± chemotherapy (CT) or CT alone. Compared to healthy co...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 327dcead-77d4-5736-9360-0b85aee20e89
- DOI
- 10.21203/rs.3.rs-7016519/v1
